Thioredoxins (Trx) are small ubiquitous proteins that participate in different cellular processes via redox-mediated reactions. We report here the identification and characterization of a novel member of the thioredoxin family in humans, named Sptrx (sperm-specific trx), the first with a tissue-specific distribution, located exclusively in spermatozoa. Sptrx open reading frame encodes for a protein of 486 amino acids composed of two clear domains: an N-terminal domain consisting of 23 highly conserved repetitions of a 15-residue motif and a C-terminal domain typical of thioredoxins. Northern analysis and in situ hybridization shows that Sptrx mRNA is only expressed in human testis, specifically in round and elongating spermatids. Immunostaining of human testis sections identified Sptrx protein in spermatids, while immunofluorescence and immunogold electron microscopy analysis demonstrated Sptrx localization in the cytoplasmic droplet of ejaculated sperm. Sptrx appears to have a multimeric structure in native conditions and is able to reduce insulin disulfide bonds in the presence of NADPH and thioredoxin reductase. During mammalian spermiogenesis in testis seminiferous tubules and later maturation in epididymis, extensive reorganization of disulfide bonds is required to stabilize cytoskeletal sperm structures. However, the molecular mechanisms that control these processes are not known. The identification of Sptrx with an expression pattern restricted to the postmeiotic phase of spermatogenesis, when the sperm tail is organized, suggests that Sptrx might be an important factor in regulating critical steps of human spermiogenesis.
Thioredoxins (Trx)1 are low molecular weight proteins (12 kDa) that catalyze thiol-disulfide redox reactions by the reversible oxidation of the cysteine residues of their conserved active site WCGPC (1). Thioredoxins are maintained in their active reduced form by the flavoenzyme thioredoxin reductase that uses the reducing power of NADPH, which constitutes the so-called thioredoxin system (2). All of the organisms from bacteria to humans appear to have at least one complete thioredoxin system, and the progressive complexity of eukaryotic organisms is also reflected in the increasing number of thioredoxin systems. Thus, Escherichia coli contains two thioredoxins and one thioredoxin reductase; yeast has two thioredoxin systems, one in cytosol and the other one in mitochondria; and photosynthetic organisms have several thioredoxin systems in different cellular compartments including chloroplasts. Finally, mammalian cells have at least two thioredoxin systems located in the cytosol and mitochondria, respectively (3). Different functions have been assigned to thioredoxins relying mostly on their general disulfide-reductase activity. In mammals, cytosolic Trx has been shown to be an antioxidant; a modulator of apoptosis, cell growth, and differentiation; and also a regulator of the DNA-binding activity of several transcription factors (following translocation into the nucleus), while the func...